Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease

Authors: M. Soulié, Y. Stephan, M. Durand, I. Lima-Posada, R. Palacios-Ramírez, L. Nicol, N. Lopez-Andres, P. Mulder, F. Jaisser

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)

Subject Terms: Cardiorenal, Chronic kidney disease, Mineralocorticoid receptor antagonist, Sodium-glucose cotransporter-2 inhibitor, 5/6 nephrectomy, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/15f1b047b07849c4b85225bbf161495d